Literature DB >> 11705478

Learning from the cerivastatin experience.

J A Farmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11705478     DOI： 10.1016/S0140-6736(01)06489-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  How can research ethics committees protect patients better?

Authors:  Silvio Garattini; Vittorio Bertele; Luca Li Bassi
Journal:  BMJ       Date:  2003-05-31

2.  Limited adherence to safety instructions in drug leaflets.

Authors:  H J Derijks; G H P De Koning; A K Mantel-Teeuwisse; A C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 3.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes.

Authors:  Thomayant Prueksaritanont; Karen M Richards; Yue Qiu; Kristine Strong-Basalyga; Alisha Miller; Chunze Li; Roy Eisenhandler; Edward J Carlini
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  Statin wars following coronary revascularization--evidence-based clinical practice?

Authors:  James M Brophy; Vania Costa
Journal:  Can J Cardiol       Date:  2006-01       Impact factor: 5.223

6.  Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil.

Authors:  Cunzhong Shi; Luo Min; Julin Yang; Manyun Dai; Danjun Song; Huiying Hua; Gangming Xu; Frank J Gonzalez; Aiming Liu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-05-10       Impact factor: 4.080

7.  Early detection of drug interactions utilizing a computerized drug prescription handling system-focus on cerivastatin-gemfibrozil.

Authors:  Tomás Morera; Guillermo Gervasini; Juan A Carrillo; Julio Benitez
Journal:  Eur J Clin Pharmacol       Date:  2004-01-21       Impact factor: 2.953

Review 8.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 9.  Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.

Authors:  Rui Li; Hugh A Barton; Manthena V Varma
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

10.  A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin.

Authors:  Chikako Ishikawa; Hiroshi Ozaki; Toshiaki Nakajima; Toshihiro Ishii; Saburo Kanai; Saeko Anjo; Kohji Shirai; Ituro Inoue
Journal:  J Hum Genet       Date:  2004-09-09       Impact factor: 3.172
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.